Cetilistat Related Products


Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Cetilistat, pharmacopeial and non-pharmacopeial Cetilistat impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Cetilistat impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Cetilistat-related products are thoroughly characterized. Cetilistat products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Cetilistat

N° de SZ CAT:: SZ-C235001
Número CAS: 282526-98-1
Mol.F.: C25H39NO3
Peso Molecular: 401.6
Status de Fatura: Custom Synthesis
categories
products.recentlyviewedproducts